Top

Gepubliceerd in:

01-06-2012 | Special Article

Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals

Auteurs: F. Alfonso, A. Timmis, F. J. Pinto, G. Ambrosio, H. Ector, P. Kulakowski, P. Vardas, on behalf of the Editors’ Network European Society of Cardiology Task Force

Gepubliceerd in: Netherlands Heart Journal | Uitgave 6/2012

Abstract

Disclosure of potential conflicts of interest (COI) is used by biomedical journals to guarantee credibility and transparency of the scientific process. COI disclosure, however, is not systematically nor consistently dealt with by journals. Recent joint editorial efforts paved the way towards the implementation of uniform vehicles for COI disclosure. This paper provides a comprehensive editorial perspective on classical COI-related issues. New insights into current COI policies and practices among European Society of Cardiology national cardiovascular journals, as derived from a cross-sectional survey using a standardised questionnaire, are discussed.

vorige artikel The pathophysiological basis of pharmacological interventions in CAVD

volgende artikel Subclavian artery perforation complicating coronary angiography

International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. (Updated October 2008). Available: http://www.icmje.org/.

Council of Science Editors. CSE’s White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005–2006). Available: http://www.CouncilScienceEditors.org

World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. Available: http://www.wame.org/resources/ethics-resources.

Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. Available: http://publicationethics.org/resources/guidelines .

Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004;57(6):592–3.PubMedCrossRef

Blum JA, Freeman K, Dart RC, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009;302(20):2230–4.PubMedCrossRef

Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med. 2006;21(12):1248–52.PubMedCrossRef

Bekelman JE, MPhil YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454–65.PubMedCrossRef

DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA. 2009;302(2):198–9.PubMedCrossRef

10.

Studdert DM, Mello MM, Phil M, et al. Financial conflicts of interest in physicians´ relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891–900.PubMedCrossRef

11.

Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009;361(19):1896–7.PubMedCrossRef

12.

Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures - The updated ICMJE conflict of interest reporting form. N Engl J Med. 2010;363(2):188–9.PubMedCrossRef

13.

Alfonso F, Ambrosio G, Pinto FJ, et al. European National Society cardiovascular journals. Background, rationale and mission statement of the “Editors’ Club”. Rev Esp Cardiol. 2008;61(6):644–50.PubMedCrossRef

14.

Alfonso F, Ambrosio G, Pinto FJ, et al. Editors’ Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the ‘Editors’ Network’. Eur Heart J. 2010;31(1):26–8.PubMedCrossRef

15.

Mills P, Timmis A, Huber K, et al. The role of European national journals in education. Heart. 2009;95(24):e3.PubMedCrossRef

16.

Alfonso F. The Editors’ Network of the European Society of Cardiology. Eur Heart J. 2011;32(8):919–21.

17.

Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med. 2008;358(17):1850–1.PubMedCrossRef

18.

Simone J. More interest in conflicts of interest. Lancet Oncol. 2009;10:836–7.PubMedCrossRef

19.

Conti RC. Conflict of interest. Clin Cardiol. 2009;32:666–7.CrossRef

20.

Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA. 2005;294(1):110–1.PubMedCrossRef

21.

Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005;118(2):99–100.PubMedCrossRef

22.

Alpert JS. Doctors and the drug-industry: further thoughts for dealing with potential conflicts of interest? Am J Med. 2008;121(4):253–5.PubMedCrossRef

23.

Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84(9):771–5.PubMedCrossRef

24.

Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol. 2009;54(2):177–9.PubMedCrossRef

25.

Bodenheimer T. The uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342(20):1539–44.PubMedCrossRef

26.

Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ. 2009;339:b4949.PubMedCrossRef

27.

Davidoff F, de Angelis CD, Drazen JM, et al. International Committee of Medical Journal Editors. Sponsorship, authorship and accountability. Lancet. 2001;358:854–6.PubMedCrossRef

28.

Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003;289(6):741–6.PubMedCrossRef

29.

Alfonso F, Segovia J, Heras M, et al. Publication of clinical trials in scientific journals: Editorial issues. Rev Esp Cardiol. 2006;59(11):1206–14.PubMedCrossRef

30.

Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332(7549):1061–4.PubMedCrossRef

31.

Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167–70.PubMedCrossRef

32.

Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004;117(11):842–5.PubMedCrossRef

33.

Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc. 2009;84(9):811–21.PubMedCrossRef

34.

Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290(4):495–501.CrossRef

35.

Chan AW, Krleza-Jerić K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004;171(7):735–40.PubMedCrossRef

36.

Alfonso F, Bermejo J, Segovia J. Duplicate or redundant publication: can we afford it? Rev Esp Cardiol. 2005;58(5):601–4.PubMedCrossRef

37.

Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004;170(4):481–3.PubMed

38.

Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325(7358):249.PubMedCrossRef

39.

Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000–2005. JAMA. 2006;295(19):2270–4.PubMedCrossRef

40.

Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics. 2001;7(2):205–18.PubMedCrossRef

41.

Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics. 2007;13(2):147–57.PubMedCrossRef

42.

Weinfurt KP, Seils DM, Tzeng JP, et al. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE. 2008;3(5):e2128.PubMedCrossRef

43.

Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005;2(5):e138.PubMedCrossRef

44.

Editors T. Publishing commentary by authors with potential conflicts of interest: When, Why and How. Annals Intern Med. 2004;141(1):73–4.

45.

Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol. 2008;51(19):1911.PubMedCrossRef

46.

Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009;339:b3139.PubMedCrossRef

47.

Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA. 1993;269(21):2782–4.PubMedCrossRef

48.

Avanzas P, Bayes-Genis A, Pérez de Isla L, et al. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011;64(5):427–9.PubMedCrossRef

49.

Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology Eur Heart J. 2012 March; 33(5): 666–674

Titel: Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
Auteurs: F. Alfonso
A. Timmis
F. J. Pinto
G. Ambrosio
H. Ector
P. Kulakowski
P. Vardas
on behalf of the Editors’ Network European Society of Cardiology Task Force
Publicatiedatum: 01-06-2012
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 6/2012
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-012-0277-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2012

Adults with Down syndrome have reduced cardiac response after light exercise testing

It’s a small world after all

Subclavian artery perforation complicating coronary angiography

An undulating giant left ventricular apical thrombus after myocardial infarction

Conflicts of interest: call for new editorial policies in European national journals

The pathophysiological basis of pharmacological interventions in CAVD